학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,562건 | 목록 1~20
Academic Journal
Frost N; Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin (Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health), Berlin, Germany; National Center for Tumor Diseases (NCT), NCT Berlin, Berlin, Germany. Electronic address: Nikolaj.frost@charite.de.; Joosten M; Institute of Pathology, Charité - Universitätsmedizin Berlin (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Franzen J; Institute of Pathology, Charité - Universitätsmedizin Berlin (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Helmholtz Imaging, Berlin, Germany; Digital Engineering Faculty, University of Potsdam, Potsdam, Germany.; Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; National Center for Tumor Diseases (NCT), NCT West, Essen, Germany.; Rasokat A; Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Kulhavy J; Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken and Bavarian Cancer Research Center (BZKF), University Hospital Wuerzburg, Wuerzburg, Germany.; Kollmeier J; Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin, Germany; Berlin Lung Institute, Berlin, Germany.; Reinmuth N; Asklepios Lung Clinic, Member of the German Center for Lung Research (DZL), Munich-Gauting, Germany.; Grohé C; Klinik für Pneumologie-Evangelische Lungenklinik Berlin Buch, Berlin, Germany.; Roeper J; Department of Hematology and Oncology, Pius-Hospital, University Dept. of Internal Medicine - Oncology, Oldenburg, Germany.; Rittmeyer A; Department of Thoracic Oncology, LKI Lungenfachklinik Immenhausen, Immenhausen, Germany.; Heinzen S; Hematology/Oncology, Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany.; Wermke M; Department of Thoracic Oncology, Carl-Gustav-Carus Dresden University Hospital, Dresden, Germany.; Wesseler C; Department of Thoracic Oncology, Asklepios Klinikum Harburg, Hamburg, Germany.; Christopoulos P; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Kauffmann-Guerrero D; Department of Medicine V, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL- CPCM), Munich, Germany.; Althoff A; Department of Pulmonology, Thoraxzentrum Offenbach, Sana Klinikum Offenbach, Offenbach, Germany.; Bleckmann A; Department of Medicine A for Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.; Collienne M; DKFZ-Hector Cancer Institute and Department of Personalized Oncology at the University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), Heidelberg, Germany.; Berezucki E; Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.; Overbeck T; Department of Hematology and Medical Oncology, University Medical Center Göttingen and Lungentumorzentrum Universität Göttingen, Göttingen, Germany.; Kropf-Sanchen C; DKFZ-Hector Cancer Institute and Department of Personalized Oncology at the University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), Heidelberg, Germany; Division of Pulmonology, Department of Internal Medicine II, Ulm University Medical Center, Ulm, Germany.; Griesinger F; Department of Hematology and Oncology, Pius-Hospital, University Dept. of Internal Medicine - Oncology, Oldenburg, Germany.; Sebastian M; Hematology/Oncology, Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany.; Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; National Center for Tumor Diseases (NCT), NCT West, Essen, Germany.; Braun S; Institute of Pathology, Sana Clinic Offenbach GmbH, Offenbach, Germany.; Wenzel C; Institute for Pathology, University Hospital Carl-Gustav-Carus Dresden, Technische Universität Dresden, Dresden, Germany.; Furth C; Department of Nuclear Medicine, Charité Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Wolf J; Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Bischoff P; Institute of Pathology, Charité - Universitätsmedizin Berlin (Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Reck M; Lung Clinic Großhansdorf, Airway Research Center North, German Center of Lung Research, Großhansdorf, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
In Nuclear Physics B (Proceedings Supplements) 2001 91(1):91-98
Academic Journal
In Coastal Engineering 2001 43(3):247-263
검색 결과 제한하기
제한된 항목
[AR] Wolf, J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어